232 related articles for article (PubMed ID: 16806422)
1. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis.
Hudolin T; Juretic A; Pasini J; Tomas D; Spagnoli GC; Heberer M; Dimanovski J; Kruslin B
Urology; 2006 Jul; 68(1):205-7. PubMed ID: 16806422
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
[TBL] [Abstract][Full Text] [Related]
3. Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 cancer-testis antigens in fetal testis.
Hudolin T; Kastelan Z; Derezić D; Basić-Jukić N; Cesare Spagnoli G; Juretić A; Jezek D
Acta Dermatovenerol Croat; 2009; 17(2):103-7. PubMed ID: 19595265
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
[TBL] [Abstract][Full Text] [Related]
5. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
6. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
[TBL] [Abstract][Full Text] [Related]
7. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
8. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma.
Kienstra MA; Neel HB; Strome SE; Roche P
Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237
[TBL] [Abstract][Full Text] [Related]
9. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
[TBL] [Abstract][Full Text] [Related]
10. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
Wölfl M; Jungbluth AA; Garrido F; Cabrera T; Meyen-Southard S; Spitz R; Ernestus K; Berthold F
Cancer Immunol Immunother; 2005 Apr; 54(4):400-6. PubMed ID: 15449039
[TBL] [Abstract][Full Text] [Related]
11. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
13. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
[TBL] [Abstract][Full Text] [Related]
16. Melanoma or not? Cancer testis antigens may help.
Lüftl M; Schuler G; Jungbluth AA
Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517
[TBL] [Abstract][Full Text] [Related]
17. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
Bolli M; Schultz-Thater E; Zajac P; Guller U; Feder C; Sanguedolce F; Carafa V; Terracciano L; Hudolin T; Spagnoli GC; Tornillo L
Int J Cancer; 2005 Jul; 115(6):960-6. PubMed ID: 15751033
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
